Clinical Trial

Comparison of Hepatectomy and Local Ablation for Resectable Synchronous and Metachronous Colorectal Liver Metastasis

Study acronym: HELARC
Unknown
View on ClinicalTrials.gov →
Record status
This record was last updated September 1, 2016 (before its estimated July 2021 completion). Its status may not reflect the trial's current state.
Summary
The surgical and local ablation strategy for the treatment of resectable synchronous and metachronous colorectal liver metastases(CRLM) has not still been defined. The purpose of this study is to compare two treatment strategies in which simultaneous resection of both primary and secondary tumor of synchronous CRLM(SCRLM) and resection of metachronous CRLM(MCRLM) is compared with resection of primary tumor and ablation of secondary tumor in SCRLM and ablation of MCRLM. Endpoints include the rate of severe complications and survival.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Unknown 2026-08-09
Trial Details
NCT Number NCT02886104
Lead Sponsor Sixth Affiliated Hospital, Sun Yat-sen University
Collaborators: First Affiliated Hospital, Sun Yat-Sen University, Second Affiliated Hospital, Sun Yat-Sen University
Conditions Secondary Malignant Neoplasm of Liver
Enrollment 548 participants
Start Date 2016-08
Primary Completion 2021-07 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2016-09-01